Demant Logo
DK0060738599
A2AKB9
WILLF

Demant

Previsión

No hay datos de analistas disponibles para esta empresa.

Debates en la comunidad

Todavía no hay ninguna discusión sobre este activo.

Iniciar debate

  • Demant rises sharply after double upgrade by BofA

    The Demant share climbed about 3.5% today after BofA Securities raised its rating from "Underperform" to "Buy" and increased the price target from DKK 170 to DKK 280. BofA justified the upgrade with stronger market growth in the first quarter, improved demand for the Oticon Zeal product, raised EPS forecasts for 2026 and 2027, and lower capital costs. The revaluation pushed the stock toward the new price target and supports a recovery thesis for Demant. » Más en de.investing.com


  • Demant exceeds Q1 revenue forecast thanks to Oticon Zeal and acquisitions

    Demant reports Q1 2026 revenue of USD 6.25 billion, 2.46% above the USD 6.1 billion forecast. Total growth was 16%, driven by 6% organic growth and 10% acquisition-driven growth (mainly from the acquisition of KIND); EPS met expectations. Strong sales in North America and Europe and the launch of Oticon Zeal lifted the gross margin, and the stock rose 0.97% after hours to USD 209.2. Management confirms the 2026 outlook and remains confident about further product launches in the second half of the year. » Más en de.investing.com


  • Demant beats Q1 revenue forecast thanks to hearing-aid growth, stock jumps sharply

    Demant reported Q1 2026 revenue of USD 6.25 billion, exceeding the USD 6.1 billion forecast. Drivers were 6% organic growth and roughly 10% acquisition-driven growth following the integration of KIND, as well as the product launch of Oticon Seal, which led to an expansion of gross margin. The stock rose 10.9% to USD 232 after the announcement. Management confirmed the full-year guidance for organic growth of 3–6% and an EBIT range of DKK 4.1–4.5 billion, but cited currency risks and potential market saturation as challenges. » Más en de.investing.com


  • William Demant falls 13% after quarterly results

    William Demant reported acquisition-driven revenue growth in Q4 2025, while EBIT before special items fell 10% and free cash flow declined 11%. The takeover of the KIND group increased net debt and pushed the leverage ratio to 3.4, prompting management to suspend share buybacks and prioritize debt reduction. Newly introduced premium hearing aid Oticon Seal is expected to drive growth but failed to reassure investors. For 2026 the company expects organic growth of 3–6% and an EBIT of DKK 4.1–4.5 billion; a return to the leverage target is planned within 18–24 months. » Más en de.investing.com


  • Demant acquires Kind and becomes Germany's largest hearing-aid chain

    The Federal Cartel Office has approved the takeover of around 600 Kind branches by the Danish group Demant. Demant is also buying Audifon, the manufacturer owned by Kind, combining about 350 of its own branches in Germany with the acquired locations. The authority considers there to be sufficient competition from other chains, opticians and regional providers despite the merger. The Kind brand name is to be retained, and the previous owning family will withdraw after the transaction is completed. » Más en spiegel.de

En 2000, Demant ya ha pagado 0,0802 € en dividendos. El último pago fue en mayo de 2000.

Datos financieros

En el último trimestre, Demant tuvo unos ingresos de 1730,38 M € y un beneficio neto de 158,11 M €

(EUR) junio de 2026
YoY
Ingresos 1730,38 M -
Beneficio bruto 1336,44 M -
Beneficio neto 158,11 M -
EBITDA 413,66 M -

Datos fundamentales

Métrica Valor
Capitalización bursátil
10,26 mil M €
Número de acciones
210,9 M
Máximo/mínimo de 52 semanas
49,03 € - 25,57 €
Dividendos No
Beta
0,76
Ratio P/E
44,72
Ratio PEG
-1,54
Ratio P/B
6,41
Ratio P/S
2,93

Perfil de la empresa

Demant A/S, una empresa de tecnología auditiva y audiología, desarrolla, fabrica y vende productos y equipos para mejorar la audición de las personas en Europa, Norteamérica, el Pacífico, Asia y a nivel internacional. Opera en dos segmentos, Hearing Healthcare y Communications. El segmento Hearing Healthcare ofrece implantes y audífonos, servicios de cuidado auditivo y productos de diagnóstico. El segmento Communications proporciona auriculares para el trabajo colaborativo y el mercado de los videojuegos bajo la marca EPOS. La empresa era conocida anteriormente como William Demant Holding A/S y cambió su nombre a Demant A/S en marzo de 2019. Demant A/S fue fundada en 1904 y tiene su sede en Smørum, Dinamarca.

Nombre
Demant
CEO
Søren Nielsen
Sede Smørum, ze
Dinamarca
Sitio web
Sector
Salud
Industria
Equipos y suministros sanitarios
Salida a bolsa
08/05/2000
Empleados 26.704

Símbolos bursátiles

Bolsa Símbolo
Pnk
WILLF
Nasdaq Copenhagen
DEMANT.CO
Copenhagen
DEMANT.CO
Frankfurt
WDH1.F
Düsseldorf
WDH1.DU
London
0RGT.L
SIX
WDH.SW
München
WDH1.MU
Wien
DEMA.VI
🍪

Parqet  usa cookies. Más información